Commercial Due Diligence on a Next Generation Medical Training Tool

Commercial Due Diligence on a Next Generation Medical Training Tool

Christine O'Connell • March 18, 2021
Christine O'Connell • March 18, 2021

Share

Client and project overview

  • Conducted commercial due diligence (CDD) for a leading B2B data and information business.
  • Focused on evaluating the commercial attractiveness of the 3DDA solution market. We also validated the investment thesis – that the target would be a strategic extension for our client’s medical book assets because it capitalized on the growing adoption of digital and virtual reality technologies


Key questions

As part of our CDD process, we focused on the following questions:

  • What was the sub-segment size and notional opportunity for 3DDA tools?
  • Who are the addressable users?
  • What is the range of content and related tools used by students and medical /nursing schools for foundational and advanced anatomy courses?
  • To what extent do current solutions address customer needs?
  • What were the relative strengths and weaknesses of the target and competitors’ capabilities and products across the identified use cases/feature set?
  • What were the synergies between our client the target business?


Methodology highlights

  • Conducted targeted interviews with market experts, current and prospective customers of the target company, competitors’ B2B customers, our client’s B2B customers, and competing vendors
  • Sized the relevant sub-segment using both supply and demand-side methodology
  • Re-built the business plan for both B2B and B2C customers within a tight timeframe with limited access to target management/customer data


Results

Based on our insights, our client acquired the company successfully two months after we delivered the project.

Read More

By Rob Larson, Jordan Abrams February 17, 2026
A recap of Grant Thornton Stax and Raymond James’ healthcare breakfast on PE investment opportunities across the pharma tech ecosystem.
How AI is Reshaping Vertical SaaS
By Kelsey Chisholm & Palash Misra February 12, 2026
AI is driving a bifurcation between surface-layer productivity tools and core operational platforms within vertical software. Learn how Ai is reshaping vertical SaaS here.
Vault Top 50: Four Years Running
February 11, 2026
For four straight years, Grant Thornton Stax has earned a spot on the Vault Consulting Top 50 list of the best consulting firms to work for in North America. Read more here.
Grant Thornton Stax Advises Alma on its Acquisition by Spring Health​
February 3, 2026
Grant Thornton Stax supported Alma, a membership-based platform that aids mental health clinicians in building thriving private practices, on its recent acquisition by Spring Health. Read more.
Grant Thornton Stax Announces Winter 2026 Promotions
January 30, 2026
Grant Thornton Stax is pleased to announce our 2026 winter promotions. Click to learn more.
Stax Consultant Spotlight: Chris Flynn
January 30, 2026
Grant Thornton Stax Consultant Chris Flynn sits down for a Q&A to share his experience and insights from his tenure with our firm. Read the full interview here.
Show More